# Kinsa

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/kinsa

- Industry: Medical Devices & Equipment
- Headquarters: San Francisco, US
- Website: www.kinsahealth.com
- Total disclosed funding: $26M
- Latest round: Series B (Nov 10, 2021)
- Investors on record: 7

## About

Kinsa Inc. develops innovative health monitoring solutions through internet-connected thermometers and advanced software, empowering users with timely health insights to manage infectious illnesses effectively.Founded in 2012 in San Francisco, US, Kinsa Inc. specializes in advanced health monitoring solutions. The company has raised a total of USD 7.00 mn, including USD 7.00 mn in its latest funding round, Series B. The founder, Inder Singh, also serves as CEO, having previously held roles in other health tech ventures.Kinsa specializes in developing advanced health monitoring solutions that utilize internet-connected thermometers and sophisticated software systems. The company's core offerings include smart thermometers that collect symptom data from users, which is then analyzed through machine learning and epidemiological models to forecast the spread of infectious illnesses. These tools are designed to guide users—whether families or healthcare organizations—toward timely care and preventive measures, significantly reducing the spread of illnesses. Kinsa's products are particularly targeted at healthcare systems, retail pharmacies, and individual families, providing real-time insights that help manage healthcare demands during infectious disease surges. The company’s solutions are marketed across various geographical regions, notably in the United States and Canada, where their products are available through major retail channels.Kinsa generates revenue through a combination of direct-to-consumer sales and partnerships with healthcare providers and retail pharmacies. The transaction structure typically involves selling smart thermometers and subscriptions to their accompanying health tracking software, which enhances user engagement and provides actionable health insights. Retailers and wholesalers distribute Kinsa products, allowing them to reach a broader audience while providing families with accessible health monitoring solutions. Kinsa's flagship product, the internet-connected thermometer, serves as a crucial tool in their revenue model, enabling users to contribute symptom data that can be analyzed for community health trends. Pricing plans for Kinsa's products and services are strategically developed to cater to both individual consumers and institutional buyers, ensuring a comprehensive approach to health management across various market segments.Kinsa Inc. is focused on launching new health monitoring products and expanding its market presence. Funding from the recent Series B round will be utilized to support these initiatives. Specific plans include enhancing product offerings designed for both consumers and healthcare providers, with a view to penetrate new markets in North America by the end of 2024. The support from new investor Reform Ventures will further assist in these growth endeavors.

## Funding rounds

- Series B, Nov 10, 2021 — Alumni Ventures Group
- Series B, Dec 23, 2016, $14M — Kleiner Perkins, GSR Ventures, FirstMark Capital
- Series A, Dec 11, 2014, $9.6M — Kleiner Perkins, FirstMark Capital, ZenStone Venture Capital
- Seed, Aug 14, 2012, $2M — IA Ventures, Founder Collective

## Investors

- IA Ventures (https://capitalatlas.ai/funds/ia-ventures) — Seed
- Founder Collective (https://capitalatlas.ai/funds/founder-collective) — Seed
- Kleiner Perkins (https://capitalatlas.ai/funds/kleiner-perkins) — Series A, Series B
- FirstMark Capital (https://capitalatlas.ai/funds/firstmark-capital) — Series A, Series B
- ZenStone Venture Capital (https://capitalatlas.ai/funds/zenstone-venture-capital) — Series A
- GSR Ventures (https://capitalatlas.ai/funds/gsr-ventures) — Series B
- Alumni Ventures Group (https://capitalatlas.ai/funds/alumni-ventures-group) — Series B